Official primary source: CCP Phase-I merger assessment announced 20 October 2026; Competition Act 2010 section 31(1)(d)(i) · Reviewed 26 October 2026. Legal effect, provisional status and dates are identified below; the full official document and any later amendments govern.
The Phase-I authorisation is transaction-specific under section 31(1)(d)(i); it does not dispense with other corporate or transactional approvals.
Which proposed acquisition CCP approved
On 20 October 2026 the Competition Commission of Pakistan reported its Phase-I clearance of Lotte Chemical Pakistan Limited's proposed acquisition of a shareholding in Engro Polymer & Chemicals Limited from Engro Corporation Limited. Approval followed competition assessment under the Competition Act, 2010.
CCP identified national product markets for polyvinyl chloride (PVC), caustic soda and hydrogen peroxide as relevant to the target's activities. Lotte Chemical Pakistan manufactures purified terephthalic acid (PTA), a feedstock used in polyester and polyethylene terephthalate (PET), and did not compete in the three defined target-product markets.
The regulator also observed that the acquirer's associated entities did not purchase products from the target. It accordingly found neither a horizontal nor a vertical overlap arising from the parties' activities.
Market analysis and statutory clearance grounds
CCP acknowledged that Engro Polymer & Chemicals is the only domestic PVC manufacturer but noted that imported PVC provides competitive constraints. The target was described as having lower market shares in caustic soda and hydrogen peroxide, with competitors operating in those markets.
The transaction changes ownership and control of the target, but does not itself increase its production, sales or output. On that basis, CCP did not expect the transaction to increase concentration, create entry barriers or materially enhance market power.
The Commission authorised the transaction under section 31(1)(d)(i) of the Competition Act, 2010 after concluding it was unlikely to substantially lessen competition or create/strengthen a dominant position in the defined relevant markets.
Implications for future merger notifications
The decision illustrates why Phase-I assessment turns on proper definition of product and geographic markets, relationships between the buyer's existing group operations and target activities, the role of imports, and credible economic analysis of incremental effects.
Transaction teams should maintain reliable group-level business information, potential horizontal or vertical linkages and market-share analyses when seeking merger authorisation. Clearance of this named transaction does not immunise later changes in structure or separate acquisitions.
Completion also remains subject to applicable corporate, stock-exchange, contractual and other regulatory requirements; CCP's press release is evidence of competition authorisation only.
Why this development matters
M&A counsel should treat this as an example of Phase-I merger analysis, not a general exemption for chemicals-sector acquisitions.
Specific steps for affected organisations
- Review target and acquirer group activities for actual horizontal and vertical overlaps.
- Document relevant product and geographic markets, market shares and import competition.
- Verify the intended transaction falls within the scope of the CCP authorisation.
- Separately assess SECP/PSX disclosures, shareholder and contractual approvals.
Timing and legal status
CCP's transaction-specific merger authorisation announced 20 October 2026; no future effective date or conditions stated in the published release.
The release confirms a Phase-I competition authorisation; it does not prove transaction completion or resolve other approvals.
Competition Commission of Pakistan — official press release, 20 October 2026